(Q46517224)

22 December 2017

title

PON1Q192R polymorphism is associated with lipid profile in Mexican men with Mayan ascendancy (English)

1 reference

22 December 2017

author name string

Norma Pérez-Herrera

1

1 reference

22 December 2017

Carlos May-Pech

2

1 reference

22 December 2017

Isabel Hernández-Ochoa

3

1 reference

22 December 2017

Jorge Castro-Mañé

4

1 reference

22 December 2017

Elizabeth Rojas-García

5

1 reference

22 December 2017

Víctor Hugo Borja-Aburto

6

1 reference

22 December 2017

Teresa Castillo-Burguete

7

1 reference

22 December 2017

Betzabet Quintanilla-Vega

8

1 reference

22 December 2017

publication date

4 June 2008

1 reference

22 December 2017

Experimental and Molecular Pathology

published in

1 reference

22 December 2017

volume

85

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

129-134

1 reference

22 December 2017

Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

DNA Polymorphisms of the Apolipoprotein AI/CIII/ AIV Gene Cluster Influence Plasma Cholesterol and Triglyceride Levels in the Mayans of the Yucat&aacute;n Peninsula, Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Increased influence of genetic variation on PON1 activity in neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Paraoxonase and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Distribution of paraoxonase PON1 gene polymorphisms in Mexican populations. Its role in the lipid profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

A study of the polymorphism and ethnic distribution differences of human serum paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Polymorphic Alu insertions among Mayan populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The PON1192RR genotype is associated with a higher prevalence of arterial hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Genetic polymorphisms and activity of PON1 in a Mexican population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Effect of physical activity on lipid levels in a population-based sample of men with and without the Arg192 variant of the human paraoxonase gene

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

inferred from DOI database lookup

7 January 2021

based on heuristic

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

10.1016/J.YEXMP.2008.05.003

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

18582459

1 reference

22 December 2017